Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Severe malaria remains a major cause of global morbidity and mortality. Despite the use of potent anti-parasitic agents, the mortality rate in severe malaria remains high. Adjunctive therapies that target the underlying pathophysiolo...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-07-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/12/1/176 |